9-(2-hydroxy-3-nonyl)adenine,
9-(2-hydroxy-3-nonyl)adenine hydrochloride,
9-(2-hydroxy-3-nonyl)adenine monohycrochloride,
9-(2-hydroxy-3-nonyl)adenine monohycrochloride, (erythro-R*,S*)-isomer,
9-(2-hydroxy-3-nonyl)adenine oxalate (2:1),
9-(2-hydroxy-3-nonyl)adenine oxalate (2:1), (erythro-R*,R*)-isomer,
9-(2-hydroxy-3-nonyl)adenine, (R*,S*)-(+-)-isomer,
9-(2-hydroxy-3-nonyl)adenine, (R*,S*)-isomer,
9-(2-hydroxy-3-nonyl)adenine, (R-(R*,R*))-isomer,
9-(2-hydroxy-3-nonyl)adenine, (R-(R*,S*))-isomer,
9-(2-hydroxy-3-nonyl)adenine, (S-(R*,R*))-isomer,
9-(2-hydroxy-3-nonyl)adenine, (S-(R*,S*))-isomer,
EHNA,
erythro-9-(2-hydroxy-3-nonyl)adenine,
erythro-9-(2-hydroxynon-3-yl)adenine,
erythro-9-(3-(2-hydroxynonyl))adenine,
threo-9-(2-hydroxy-3-nonyl)adenine,
EHNA hydrochloride,
58337-38-5,
EHNA,
EHNA.HCl,
51350-19-7,
ehnahydrochloride,
NSC263164,
NSC-263164,
EHNA HCl,
erythro-9-(2-Hydroxy-3-nonyl)-adenine hydrochloride,
Adenosine deaminase inhibitor,
CHEMBL1995433,
AOB3575,
9H-Purine-9-ethanol, monohydrochloride,
EHNA hydrochloride, >=98% (HPLC),
AS-16759,
9H-Purine-9-ethanol, monohydrochloride, (R*,S*)-,
rac erythro-9-(2-Hydroxy-3-nonyl)adenine Hydrochloride,
UNII-D94V1GC7I3 component VVDXNJRUNJMYOZ-VZXYPILPSA-N,
(2S,3R)-3-(6-amino-9H-purin-9-yl)nonan-2-ol hydrochloride,
erythro-9-Amino-|A-hexyl--|A-methyl-9H-purine-9-ethanol hydrochloride,
EHNA (Hydrochloride),
C14H23N5O,
C14-H23-N5-O,
erythro-9-(2-hydroxy-3-nonyl)adenine,
NSC 263164,
(R*,S*)-6-Amino-beta-hexyl-alpha-methyl-9H-purine-9-ethanol,
9H-Purine-9-ethanol, 6-amino-beta-hexyl-alpha-methyl-, (R*,S*)-,
9H-Purine-9-ethanol, 6-amino-.beta.-hexyl-.alpha.-methyl-, monohydrochloride, (R*,S*)-,